Bleeding Disorders Treatment Market - By Type (Haemophilia A, Haemophilia B, vWD, and Others), By Drug Class (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, And Others) And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 193
Status: Published
Report Code: ARI100790
There are three main types of this condition: haemophilia, clotting factor deficiency, and Von Willebrand Disease (VWD). Treatment of bleeding disorder depends on the severity and type of disorder. Various treatment options are available for bleeding disorder such as replacement therapies which include clotting factor replacement, fresh frozen plasma transfusion, platelet transfusion, iron supplementation, and medication treatments.
Most of the bleeding disorders are inherited and are not completely curable. However, various treatments are available to control the symptoms. The global bleeding disorder market is expected to be driven by the increasing number of diagnosed patients with bleeding disorders across the globe, awareness about bleeding disorder among global population, and government initiatives in developed countries toward the establishment of wide network of diagnosis and treatment centres for bleeding disorders.
Advancement in technology pertaining to research and development of new drugs and therapies for bleeding disorders is projected to fuel the growth of the bleeding disorder treatment market. The key challenges in growth of this market are lack of access to adequate treatment owing to high cost of medication and scarcity in availability of specialized health care services. Additionally, lack of availability of skilled professionals in underdeveloped and developing countries and limited health care resources hamper the growth of the market.
The key players in the bleeding disorders treatment market are Shire Plc. (earlier Baxalta) (Ireland), Bayer AG (Germany), Biogen Inc. (U.S.), CSL Behring (U.S.), Novo Nordisk (Denmark), Pfizer Inc. (U.S.), and Grifols SA (Spain).
Analyst Commentary
Based on type, the haemophilia A segment is projected to register the highest growth rate in the market. Market growth in this market segment is driven by the large number of patients suffering from haemophilia A and rising R&D investment for haemophilia product.
Based on class of drug, the recombinant coagulation factor concentrates segment is expected to witness the highest growth rate in the market. This growth is attributed to rising R&D activities and increasing focus of pharmaceutical companies on recombinant products resulting in launch of new products.
For the coming five years, APAC and LATAM regions are considered to be the lucrative markets for the bleeding disorders treatment market. Growth in this region can be attributed to increasing initiatives by local governments for increasing access to healthcare, rising disposable income, and increasing focus of global players towards emerging economies.
Segmentation
The global bleeding disorders treatment market is broadly classified by type and drug class. And region. Based on type, the market is classified as haemophilia A, haemophilia B, vWD, and others. Based on drug class, the bleeding disorders treatment market is segmented into plasma-derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, antifibrinolytics, fibrin sealants, and others.
Regional Analysis
In terms of region, the global bleeding disorder treatment market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to dominate the market owing to affordability and accessibility to health care facilities and increasing awareness about disorders through government and private institutional campaigns. According to the Haemophilia Federation of America, over 20,000 people are affected with haemophilia and 1% of population is suffering with Von Willebrand Disease (VWD). Asia Pacific is expected to witness exponential growth during the forecast period owing to emerging economies such as India and China.
The U.S. dominated the North America bleeding disorder treatment industry in 2018 owing to the high prevalence of bleeding disorders coupled with favourable insurance and reimbursement policies in the country. According to the Haemophilia Federation of America, nearly 400 newborn babies are annually diagnosed with haemophilia in the U.S. thereby increasing the demand for treatment.
India bleeding disorder treatment market is estimated to witness lucrative growth over the analysis period. The rising awareness regarding bleeding disorders and the availability of medications to treat these conditions will drive the Indian bleeding disorder treatment market. Several initiatives undertaken by the government to build the necessary healthcare infrastructure will positively impact industry growth.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Bleeding Disorders Treatment Market
Chapter 5. Global Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
5.1. Global Bleeding Disorders Treatment Market Share, By Type, 2015 - 2027 (USD Billion)
5.1.1. Haemophilia A
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Haemophilia B
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Von Willebrand Disease
5.1.3.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.4. Others
5.1.4.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027(USD Billion)
6.1. Global Bleeding Disorders Treatment Market Share, By Drug Class, 2015 - 2027 (USD Billion)
6.1.1. Plasma-derived Coagulation Factor Concentrates
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Recombinant Coagulation Factor Concentrates
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Desmopressin
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Antifibrinolytics
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.5. Fibrin Sealants
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.6. Others
6.1.6.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Bleeding Disorders Treatment Market Overview, By Geography, 2015 - 2027(USD Billion)
7.1. Global Bleeding Disorders Treatment Market Share, By Geography, 2015 - 2027(USD Billion)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 8. North America Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027(USD Billion)
8.1. North America Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
8.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.2. North America Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
8.1.3. North America Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
8.1.4. North America Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027 (USD Billion)
8.1.4.1. U.S. Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
8.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.4.1.2. U.S. Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
8.1.4.1.3. U.S. Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
8.1.4.2. Canada Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
8.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.4.2.2. Canada Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
8.1.4.2.3. Canada Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
8.1.4.3. Mexico Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
8.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.4.3.2. Mexico Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
8.1.4.3.3. Mexico Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
Chapter 9. Europe Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027(USD Billion)
9.1. Europe Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.2. Europe Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.3. Europe Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
9.1.4. Europe Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.4.1. Germany
9.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.1.2. Germany Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
9.1.4.1.3. Germany Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027(USD Billion)
9.1.4.2. France
9.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.2.2. France Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
9.1.4.2.3. France Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027(USD Billion)
9.1.4.3. UK
9.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.3.2. UK Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
9.1.4.3.3. UK Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027(USD Billion)
9.1.4.4. Italy
9.1.4.4.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.4.2. Italy Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
9.1.4.4.3. Italy Bleeding Disorders Treatment Market Overview, By Drug Class2015 - 2027(USD Billion)
9.1.4.5. Spain
9.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.5.2. Spain Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
9.1.4.5.3. Spain Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027(USD Billion)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market Size and projections, 2015 – 2027
9.1.4.6.2. Rest of Europe Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
9.1.4.6.3. Rest of Europe Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027(USD Billion)
Chapter 10. Asia Pacific Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1. Asia Pacific Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.2. Asia Pacific Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.3. Asia Pacific Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
10.1.4. Asia Pacific Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.4.1. India
10.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.4.1.2. India Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.4.1.3. India Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
10.1.4.2. China
10.1.4.2.1. Market Size and projections, 2015 - 2027(USD Billion)
10.1.4.2.2. China Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.4.2.3. China Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
10.1.4.3. Japan
10.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.4.3.2. Japan Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.4.3.3. Japan Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027(USD Billion)
10.1.4.4. South Korea
10.1.4.4.1. Market Size and projections, 2015 - 2027(USD Billion)
10.1.4.4.2. South Korea Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.4.4.3. South Korea Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.4.5.2. Rest of Asia Pacific Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.4.5.3. Rest of Asia Pacific Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
Chapter 11. Middle East & Africa Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Middle East & Africa Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.2. Middle East & Africa Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.3. Middle East & Africa Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
11.1.4. Middle East & Africa Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.4.1. GCC
11.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.4.1.2. GCC Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.4.1.3. GCC Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
11.1.4.2. South Africa
11.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.4.2.2. South Africa Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.4.2.3. South Africa Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.4.3.2. Rest of Middle East & Africa Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.4.3.3. Rest of Middle East & Africa Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
Chapter 12. South America Bleeding Disorders Treatment Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. South America Bleeding Disorders Treatment Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.2. South America Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.3. South America Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
12.1.4. South America Bleeding Disorders Treatment Market Overview, By Countries, 2015- 2026 (USD Billion)
12.1.5. Brazil
12.1.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.5.2. Brazil Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.5.3. Brazil Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
12.1.6. Argentina
12.1.6.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.6.2. Argentina Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.6.3. Argentina Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
12.1.7. Rest of South America
12.1.7.1. Market Size and projections, 2015 – 2027
12.1.7.2. Rest of South America Bleeding Disorders Treatment Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.7.3. Rest of South America Bleeding Disorders Treatment Market Overview, By Drug Class, 2015 - 2027 (USD Billion)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Technology development
Chapter 14. Key Vendor Analysis
14.1. Shire Plc
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Mice Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Bayer AG
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Mice Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Biogen Inc
14.3.1. Company overview
14.3.2. Financial performance
14.3.3. Mice Benchmarking
14.3.4. Recent initiatives
14.4. CSL Behring
14.5. Pfizer Inc
14.6. Others
Chapter 15. Bleeding Disorders Treatment Market Cost Analysis
15.1. Bleeding Disorders Treatment Market Key Technology Analysis
15.1.1. Key Technology
15.1.2. Price Trend of Key Technology
15.1.3. Key Suppliers of Technology
15.1.4. Market Concentration Rate of Technology
15.1.5. Technology
15.1.6. Labor Cost
Chapter 16. Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1. Bleeding Disorders Treatment Market Industrial Chain Analysis
16.2. Upstream Technology Sourcing
16.3. Technology Sources of Bleeding Disorders Treatment Market Major Manufacturers in 2021
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Size
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Bleeding Disorders Treatment Market share, By Type, 2020 & 2027 (%)
10. Global Bleeding Disorders Treatment Market share, by Haemophilia A, By Type, 2015 - 2027 (USD Billion)
11. Global Bleeding Disorders Treatment Market share, by Haemophilia B, By Type, 2015 - 2027 (USD Billion)
12. Global Bleeding Disorders Treatment Market share, by Von Willebrand Disease, By Type, 2015 - 2027 (USD Billion)
13. Global Bleeding Disorders Treatment Market share, by Others, By Type, 2015 - 2027 (USD Billion)
14. Global Bleeding Disorders Treatment Market share, By Drug Class, 2020 & 2027 (%)
15. Global Bleeding Disorders Treatment Market share, by Plasma-derived Coagulation Factor Concentrates, By Drug Class, 2015 - 2027 (USD Billion)
16. Global Bleeding Disorders Treatment Market share, by Recombinant Coagulation Factor Concentrates, By Drug Class, 2015 - 2027 (USD Billion)
17. Global Bleeding Disorders Treatment Market share, by Desmopressin, By Drug Class 2015 - 2027 (USD Billion)
18. Global Bleeding Disorders Treatment Market share, by Antifibrinolytics, By Drug Class 2015 - 2027 (USD Billion)
19. Global Bleeding Disorders Treatment Market share, by Fibrin Sealants, By Drug Class 2015 - 2027 (USD Billion)
20. Global Bleeding Disorders Treatment Market share, by Others, By Drug Class 2015 - 2027 (USD Billion)
21. Global Bleeding Disorders Treatment Market share, by region, 2020 & 2027 (%)
22. Global Bleeding Disorders Treatment Market share, by region, 2015 - 2027(USD Billion)
23. North America Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
24. North America Bleeding Disorders Treatment Market share, by Countries, 2020 & 2027 (%)
25. U.S. Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
26. Canada Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
27. Mexico Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
28. Europe Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
29. Europe Bleeding Disorders Treatment Market share, by Countries, 2020 & 2027 (%)
30. Spain Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
31. UK Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
32. Italy Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
33. Germany Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
34. France Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
35. Rest of Europe Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
36. Asia-Pacific Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
37. Asia-Pacific Bleeding Disorders Treatment Market share, by Countries, 2020 & 2027 (%)
38. China Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
39. India Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
40. Australia Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
41. Japan Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
42. Rest of Asia-Pacific Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
43. Middle East & Africa Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
44. Middle East & Africa Bleeding Disorders Treatment Market share, by Countries, 2020 & 2027 (%)
45. GCC Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
46. South Africa Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
47. Rest Of Middle East & Africa Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
48. South America Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
49. Brazil Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
50. Mexico Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
51. Argentina Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
52. Rest Of South America Bleeding Disorders Treatment Market, 2015 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Bleeding Disorders Treatment Market, 2015-2027 (USD Billion)
4. Weather Information Technologies requirement, by country, 2015-2027, (USD Billion)
5. North America Bleeding Disorders Treatment Market, By Type, 2015-2027 (USD Billion)
6. North America Bleeding Disorders Treatment Market, By Drug Class, 2015-2027 (USD Billion)
7. Europe Bleeding Disorders Treatment Market, By Type, 2015-2027 (USD Billion)
8. Europe Bleeding Disorders Treatment Market, By Drug Class, 2015-2027 (USD Billion)
9. Asia Pacific Bleeding Disorders Treatment Market, By Type, 2015-2027 (USD Billion)
10. Asia Pacific Bleeding Disorders Treatment Market, By Drug Class, 2015-2027 (Revenue, USD Billion)
11. Middle East & Africa Bleeding Disorders Treatment Market, By Type, 2015-2027 (USD Billion)
12. Middle East & Africa Bleeding Disorders Treatment Market, By Drug Class, 2015-2027 (USD Billion)
13. South America Bleeding Disorders Treatment Market, By Type, 2015-2027 (USD Billion)
14. South America Bleeding Disorders Treatment Market, By Drug Class, 2015-2027 (USD Billion)
15. Global Bleeding Disorders Treatment Market, Company Market Share, 2020 - 2027 (%)
16. Shire Plc : Component Benchmarking
17. Shire Plc : Financial Performance
18. Bayer AG : Component Benchmarking
19. Bayer AG : Financial Performance
20. Biogen Inc : Component Benchmarking
21. Biogen Inc : Financial Performance
22. CSL Behring : Component Benchmarking
23. CSL Behring : Financial Performance
24. Pfizer Inc : Component Benchmarking
25. Pfizer Inc : Financial Performance
The Leading Key Players in Bleeding Disorders Treatment Market
Shire Plc. (earlier Baxalta) (Ireland)
Bayer AG (Germany)
Biogen Inc. (U.S.)
CSL Behring (U.S.)
Novo Nordisk (Denmark)
Pfizer Inc. (U.S.)
Grifols SA (Spain).
